Development

A model scores all nine billion possible point mutations

development2026-09-12

Claim

AlphaGenome Atlas scored all nine billion possible point mutations, a migraine drug won a Phase 3 in a new indication, and Insilico's AI-designed rentosertib reversed aging clocks, a generative pharma first.

Reported metric: 9B mutations

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Knowledge graphopen in browser →

Reported in
Actor
Evidence for
Supersedes
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.